Federal Register / Vol. 65, No. 88 / Friday, May 5, 2000 / Notices 26221

Closed: May 22, 2000, 9 a.m. to

Adjournment.

Agenda: To review and evaluate grant

applications.

Place: Gaithersburg Hilton, 620 Perry

Parkway, Gaithersburg, MD 20877.

Contact Person: D.G. Patel, PhD, Scientific

Review Administrator, Office of Review,

National Center for Research Resources, 6705

Rockledge Drive, MSC 7965, Room 6018,

Bethesda, MD 20892–7965, 301–435–0824.

Name of Committee: National Center for

Research Resource Special Emphasis Panel

Science Education Partnership Award.

Date: June 7–8, 2000.

Closed: June 7, 2000 8 a.m. to

Adjournment.

Agenda: To review and evaluate grant

applications.

Place: Bethesda Marriott Hotel, 5151 Pooks

Hill Road, Bethesda, MD 20814.

Contact Person: Sybil A. Wellstood, PhD,

Scientific Review Administrator, Office of

Review, National Center for Research

Rources, 6705 Rockledge Drive, MSC 7965,

Room 6018, Bethesda, MD 20892–7965, 301–

435–0814.

Name of Committee: National Center for

Research Resource Initial Review Group

Comparative Medicine Review Committee.

Date: June 13–14, 2000.

Open: June 13, 2000, 8 a.m. to 9 a.m.

Agenda: To discuss program planning and

program accomplishments.

Place: Holiday Inn Bethesda, 8120

Wisconsin Avenue, Bethesda, MD 20814.

Closed: June 13, 2000, 9:00 a.m. to

Adjourmnemt.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Bethesda, 8120

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: John D. Harding, PhD,

Scientific Review Administrator, Office of

Review, National Center for Research

Resources, 6705 Rockledge Drive, MSC 7965,

Room 6018, Bethesda, MD 20892–7965, (301)

435–0810.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.306, Comparative Medicine,

93.306; 93.333, Clinical Research; 93.333,

93.371, Biomedical Technology; 93.389,

Research Infrastructure, National Institutes of

Health, HHS)

Dated: April 27, 2000.

Anna Snouffer,

Acting Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–11210 Filed 5–4–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Meeting

Pursuant to section 10(a) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

Sickle Cell Disease Advisory

Committee.

The meeting will be open to the

public, with attendance limited to space

available. Individuals who plan to

attend and need special assistance, such

as sign language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

Name of Committee: Sickle Cell Disease

Advisory Committee.

Date: June 5, 2000.

Time: 9 a.m. to 5 p.m.

Agenda: Discussion of program policies

and issues.

Place: National Institutes of Health, Two

Rockledge Center, Suite 9104, 6701

Rockledge Drive, Bethesda, MD 20892.

Contact Person: Charles M. Peterson, MD,

Director, Blood Diseases Program, Division of

Blood Diseases and Resources, National

Heart, Lung, and Blood Institute, NIH, Two

Rockledge Center, Room 10158, MSC 7950,

6701 Rockledge Drive, Bethesda, MD 20892,

301/435–0050.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.233, National Center for

Sleep Disorders Research; 93.837, Heart and

Vascular Diseases Research; 93.838, Lung

Diseases Research; 93.839, Blood Disease and

Resources Research, National Institutes of

Health, HHS)

Dated: April 26, 2000.

Anna Snouffer,

Acting Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–11204 Filed 5–4–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute of clearly unwarranted

invasion of personal privacy.

Name of Committee: Heart, Lung, and

Blood Program Project Review Committee.

Date: June 15, 2000.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn—Silver Spring, 8777

Georgia Avenue, Silver Spring, MD 20910.

Contact Person: Jeffrey H. Hurst, PhD,

Scientific Review Administrator, Review

Branch, National Heart, Lung, and Blood

Institute, National Institutes of Health, 6701

Rockledge Drive, Room 7208, Bethesda, MD

20892, 301/435–0303.

Name of Committee: Clinical Trials Review

Committee.

Date: June 25–27, 2000.

Time: 7 p.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: The Hyatt Regency Hotel, One

Bethesda Metro Center, Bethesda, MD 20814.

Contact Person: Joyce A. Hunter, PhD,

NHLBI/DEA/Review Branch, Rockledge

Building II, Room 7192, MSC 7924, 6701

Rockledge Drive, Bethesda, MD 20892, (301)

435–0287.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.233, National Center for

Sleep Disorders Research; 93.837, Heart and

Vascular Diseases Research; 93.838, Lung

Diseases Research; 93.839, Blood Diseases

and Resources Research, National Institutes

of Health, HHS)

Dated: April 26, 2000.

Anna Snouffer,

Acting Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–11205 Filed 5–4–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Arthritis and

Musculoskeletal and Skin Diseases;

Notice of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute of clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Arthritis and Musculoskeletal and Skin

Diseases Special Emphasis Panel.

Date: May 3, 2000.

Time: 3:30 p.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.